Aims: To report the six-month angiographic and two-year clinical outcome data from the first-in-man study with the Ultimaster DES, a thin-strut cobalt-chromium sirolimus-eluting stent (SE
1. Cardiovascular Center Aalst, Aalst, Belgium; 2. Clinical Centre Nis, Nis, Serbia; 3. Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia; 4. Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 5. AZ St J
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
bioresorbable polymerclinical researchsirolimus
Read next article
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial